A high-throughput glow-type aequorin assay for measuring receptor-mediated changes in intracellular calcium levels.

A glow-type aequorin luminescence assay for measuring receptor-mediated stimulation of intracellular calcium levels is described and characterized. The human 5-hydroxytryptamine(2A) receptor stably coexpressed in human embryonic kidney cells with apoaequorin was used to characterize the system and showed that following the flash reaction, a stable luminescence signal could be measured using a microplate scintillation counter for between 3 and 7 h after the addition of receptor agonist. Furthermore, this luminescence was dependent on the concentration of agonist used and gave potency values that were stable over this time period. Testing a range of 5-hydroxytryptamine(2A) receptor agonists gave the expected rank order of potency for this receptor. The glow luminescence could also be inhibited by 5-hydroxytryptamine(2A) receptor antagonists, generating affinity values that directly correlated with those determined for inhibition of the flash reaction carried out under the same buffer conditions. The assay therefore gave pharmacologically relevant data and allows a significant improvement of throughput over the traditional flash-type measurements made using an injecting luminometer.

[1]  R. Eglen,et al.  RS-102221: A Novel High Affinity and Selective, 5-HT2C Receptor Antagonist , 1997, Neuropharmacology.

[2]  Tullio Pozzan,et al.  Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin , 1992, Nature.

[3]  R Marsault,et al.  Transfected Aequorin in the Measurement of Cytosolic Ca2+ Concentration ([Ca2+]c) , 1995, The Journal of Biological Chemistry.

[4]  O. Shimomura,et al.  The relative rate of aequorin regeneration from apoaequorin and coelenterazine analogues. , 1993, The Biochemical journal.

[5]  F. Szele,et al.  High affinity agonist binding to cloned 5-hydroxytryptamine2 receptors is not sensitive to GTP analogs. , 1993, Molecular pharmacology.

[6]  A. Carlsson,et al.  Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone , 1998, Journal of Neural Transmission.

[7]  A. Saltzman,et al.  Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. , 1991, Biochemical and biophysical research communications.

[8]  B. Roth,et al.  Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. , 1998, Critical reviews in neurobiology.

[9]  S. Rees,et al.  Chimaeric Gα proteins: their potential use in drug discovery , 1999 .

[10]  M. Simon,et al.  Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.

[11]  N. Newberry,et al.  Characterisation of Human 5‐Hydroxytryptamine2A and 5‐Hydroxytryptamine2C Receptors Expressed in the Human Neuroblastoma Cell Line SH‐SY5Y: Comparative Stimulation by Hallucinogenic Drugs , 1996, Journal of neurochemistry.

[12]  M. Brownstein,et al.  Aequorin-expressing mammalian cell lines used to report Ca2+ mobilization. , 1993, Cell calcium.

[13]  B. Conklin,et al.  Recombinant Gq alpha. Mutational activation and coupling to receptors and phospholipase C. , 1992, The Journal of biological chemistry.

[14]  J. Shih,et al.  The human 5-HT2 receptor is encoded by a multiple intron-exon gene. , 1992, Brain research. Molecular brain research.

[15]  F. van Huizen,et al.  Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes. , 1992, European journal of pharmacology.

[16]  S. Peroutka.  Serotonin Receptor Variants in Disease: New Therapeutic Opportunities? , 1998, Annals of the New York Academy of Sciences.

[17]  O. Shimomura,et al.  Cause of spectral variation in the luminescence of semisynthetic aequorins. , 1995, The Biochemical journal.

[18]  S. Rees,et al.  A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. , 1997, Analytical biochemistry.

[19]  B. Roth,et al.  Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover , 1984, Neuropharmacology.

[20]  H. Kao,et al.  [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. , 1990, Molecular pharmacology.

[21]  S. Rees,et al.  G16 as a universal G protein adapter: implications for agonist screening strategies. , 1996, Trends in pharmacological sciences.